Introduction

Clinical evaluation and echocardiography are currently considered the key diagnostic tools in the initial assessment of patent ductus arteriosus (PDA) [13].

Accurate assessment of ductal dimensions and morphology is crucial in determining percutaneous closure suitability, device choice and procedural guidance, hence at the time of intervention, the vast majority of operators choose to measure the PDA angiographically [4, 5]. Recent work, extolling echocardiography’s diagnostic and guidance roles for ductal occlusion has called into question the need for routine angiography for ductal delineation [6, 7]. The potential benefits of this approach are obvious, including decreased contrast and radiation exposure and decreasing procedure time.

As literature describing a consistent correlation between two-dimensional echocardiographic and angiographic assessment is still limited [8, 9] we planned to assess the degree of correlation between these modalities in a preliminary effort to determine circumstances where echocardiography could replace angiography.

Methods

Study Population and Data Collection

We reviewed 100 consecutive patients who underwent percutaneous PDA closure at a single tertiary referral centre for congenital heart disease—Evelina London Children’s Hospital (ECH)—between August 2011 and January 2016.

Echocardiograms recorded within seven days of catheterisation as part of a preassessment and procedural angiography were reviewed. All procedures analysed were successful with no clinically significant residual leaks, pulmonary artery or aortic stenosis on predischarge echocardiography. Patients older than 16 years or with other associated significant congenital cardiac defects were excluded. Demographic and procedural data were collected from our departmental database, Heartsuite™ (Systeria, Glasgow, UK). All echocardiograms were reviewed by two experienced observers using Philips Xcelera™ software (Philips 5680 DA Best, The Netherlands). Angiograms were reviewed by two experienced operators using GE-PACS (General Electrics, Milwaukee, USA) software. Imaging was anonymised, and observers were blinded to previous measurements. For both echocardiography and angiography, ductal measurements made were those thought to have the most influence on the choice of the closure device: aortic ampulla diameter (mm), narrowest diameter (mm), pulmonary end diameter (mm) and length (mm).

Ductal morphology was also categorised according to the angiographic classification outlined by Krichenko et al. [10]. Type and size of the devices used were also recorded for comparison.

Echocardiographic Imaging Analysis

Reviewed echocardiographic images included standard parasternal views optimised to define the duct. These were usually the high parasternal window for the ductal length and the traditional “ductal view” to measure the narrowest portion, the pulmonary end and aortic ampulla. Colour Doppler mapping was also reviewed when 2D scans were insufficient for ductal characterisation as in ducts of small dimensions or unusual anatomy.

Angiography Imaging Analysis

Biplane angiograms were available for review in all cases, and measurements were attempted in both planes using the angles selected by the procedural operator. In the vast majority of cases a straight lateral projection offered most information about ductal morphology, length and diameters.

Reproducibility, Intra- and Inter-observer Variability Evaluation

Analysis of angiography versus echocardiography also included ten datasets randomly selected from the dataset and two separate experienced raters performed repeated measurements in each modality using the same protocol criteria for original ductal measurements.

Predicting Device Selection from Echocardiography and Angiography

The level of agreement between the different imaging modalities was also tested by predicting device choice from echocardiography and angiographic findings. The devices chosen to serve as references were the Amplatzer® Ductal Occluder (ADOI®) and the Ceraflex™ PDA occluder for their similarity of design and sizing criteria as well as their wide and well-known applicability in PDA closure. An experienced interventionist first reviewed the echocardiograms and was asked to predict if the ductus was suitable for device closure with ADOI/Ceraflex and if so, what size of device would be chosen. The dataset was then shuffled before the same interventionist analysed the angiography with the same set if questions [11]. These hypothetical device selections were then compared with the actual device choice. Forty ducts had been closed with ADOI® (n = 24) or Ceraflex™ (n = 16) allowing direct comparison with 40 hypothetical device choices. The complete process of data analysis is summarised in Fig. 1.

Fig. 1
figure 1

Process of data analysis summary. PDA patent ductus arteriosus, ECHO echocardiography, ADOI Amplatzer ductal occluder I

The study was approved by the institutional board of the Evelina London Children’s Hospital, and need for individual consent was waived due to the anonymised retrospective nature of the study.

Statistical Analysis

Analysis was performed using Minitab® statistical software 17, SPSS® 22 and MedCalc®. Results are presented as mean ± standard deviation or median with range. For comparison of angio- and echocardiographic measurements, a paired t test was used and Pearson’s product moment correlation coefficient was used for analysis of correlation of agreement between measurements with both imaging techniques. Bland–Altman plots were used to compare the two measurement techniques by evaluating the bias between the mean differences leading to an estimate agreement interval, within which 95% of the differences between echo and angiography measurements fall [12, 13].

Inter- and intra-operator measurements reliability was analysed using interclass correlation coefficient (ICC): a Cohen’s Kappa analysis result of >0.6 and >0.8 was considered good and excellent correlations, respectively [14, 15].

The analysis of the predicted device choice from different imaging modalities was graded depending on whether the hypothetical device choice matched or was under or overestimated. A weighted Cohen’s Kappa was performed to determine the level of agreement. All measurements were rounded to the closest millimetre to allow effective data analysis.

Results

Demographics

Data were collected on 100 consecutive patients who underwent percutaneous ductal closure. The median age was 1.6 years (range 4 months to 15.3 years), 23% were infants. Median weight was 10.75 kg (range from 5 to 75.2 kg). There was an even male to female split with 56% female patients.

Inter- and Intra-observer Agreement

Echocardiographic and angiographic measurements were analysed for intra- and inter-observer agreement using an ICC. There was excellent intra- and inter-observer agreement for both modalities (Table 1).

Table 1 ICC values for inter-operator and intra-operator variability: >0.6 = good; >0.8 = excellent agreement

Ductal Measurement Correlation between Echocardiography and Angiography

Globally, no agreement was found between echocardiography and angiography measurements. There was a tendency for echocardiography to significantly overestimate the size of both the pulmonary end and narrowest diameter and to underestimate the size of the aortic ampulla diameter. Length diameter was the exception with no significant difference between the two modalities found (Table 2).

Table 2 Mean difference values in ductal size comparing echocardiography to angiography

Ductal Morphology

There was a significant difference between the echocardiographic and angiographic morphological classification. Although there was no correlation between imaging modalities, type A was most common morphology on both echocardiography and angiography (Fig. 2).

Fig. 2
figure 2

Predicted anatomical ductal type of PDA from the different imaging modalities. ICC interclass correlation coefficient

Predicting Device Selection from Echocardiography and Angiography

For those patients who received ADOI® or Ceraflex™ device (n = 40), there was a perfect match in 29 cases (73%) with the angiographically predicted device size (Table 3) and excellent overall agreement: weighted k = 0.81 (95% CI 0.68–0.93) (Table 4). In seven cases the predictions were one device size different, and in the other four cases the reviewing interventionist did not feel that the reviewed angiographic images could be used to predict suitability and/or sizing for a device.

Table 3 Device choices made and predictions of device choice from angiography and echocardiography
Table 4 Cohen’s Kappa analysis score from the level of agreement between the different ductal imaging modalities

When using echocardiography there was a poor level of agreement with only 11 patients (28%) correctly predicted (Table 3). In 16 cases the device size was overestimated, and in five cases the size was underestimated. In eight cases the reviewing interventionist did not feel that the echocardiograms could be used to predict suitability and sizing for an ADOI®. weighted k = 0.14 (95% CI −0.03 to 0.31) (Table 4).

Discussion

The indication for ductal closure should be determined by symptoms and hemodynamic assessment based on echocardiography. Although angiography is currently considered the gold standard for precise delineation of the duct, integration of echocardiography and angiography could help to decrease radiation exposure [16].

Previous work aiming to find a significant correlation between echocardiographic and angiographic ductal assessment has been done, but the available data are limited and findings conflicting. Wong et al. [8] found no correlation between echocardiographic and angiographic measurements in a study of 27 patients. This contrasts to a 36 patient study from Ramaciotti et al. [9] who found a significant correlation between 2D echocardiography measurements of PDA minimal diameter and aortic end when assessing suitability for transcatheter closure before angiography; however, it was felt that a larger prospective series would be necessary to determine accuracy. Chen et al. [17] reported that 2D echocardiography combination with colour coded flow could be used as an alternative major guidance to angiography for first occluding attempt in a 296 patient study using a defined protocol to achieve ductal imaging prior and during the procedure. They focused on proving that device closure was feasible with echocardiographic guidance alone and there was no attempt to systematically correlate angiographic characteristics with echocardiography. In fact our observation that the echocardiogram tended to overestimate the minimal duct diameter in comparison with angiography does not contradict Chen’s findings. One could postulate that this overestimation may lead to modest oversizing of the chosen device, which would in most cases still facilitate a safe and effective closure.

To our knowledge, our data represent the largest study in a paediatric population to evaluate echocardiography’s potential to replace aortic angiography in percutaneous duct closure by systematically comparing both methods. We failed to demonstrate agreement between echocardiographic and angiographic measurements other than the length of the PDA. Whilst measurements of the narrowest diameter and the pulmonary diameter tended to be overestimated when using echocardiography, the aortic ampulla diameter tended to be underestimated. Ductal length measurement was an exception with good correlation shown between the two imaging methods. However, despite being an important feature in device selection, ductal length needs to be considered alongside the other more key measurements, in particular the minimum diameter.

No evidence of a predictable correlation or trend was found in order to predict the angiographic measurements from echo measurements. That is to say; not only did the measurements not agree, but the variation was not predictable. Considering ductal morphology; unsurprisingly, more type A ducts were found by both methods, but no agreement on characterisation was found between the two methods.

Inter- and intra-operative observer agreement in both modalities measurements was excellent (ICC > 0.8). Despite the data being correlated retrospectively and without using defined prospective imaging protocols, there were no significant systematic errors, inferring a high level of imaging quality and internal consistency.

Device selection predictions from echocardiography were inaccurate when compared with angiographic images (weighted k = 0.14 vs. 0.81, respectively) demonstrating not only that echo could not predict the device size but also that the “direction” of the error was not consistent.

The lack of agreement found between the two methods could lead to miss sizing a device and possibly affect operator’s confidence if echocardiographic measurements were exclusively used.

Study Limitations

Echocardiographic quantification for the study was obtained retrospectively, from imaging acquired during routine preassessment of patients attending for percutaneous duct occlusion. There was no specific echo protocol designed to assess device size selection or procedure guidance. It is likely that data acquired prospectively with sophisticated acquisition and measurement protocols would improve accuracy and increase the level of agreement between the imaging methods. A study involving blinded, prospective, standardised angiographic and echocardiographic assessment would help to further test our hypothesis.

Conclusion

Overall, our data do not suggest that accurate correlation exists between routine pre-operative echocardiography and angiographic imaging. Angiographic assessment of ductal anatomy, despite information gleaned from diagnostic echocardiography, remains the gold standard method for assessment and guidance at the time of device closure. Based on our data, an appropriate device selection cannot be based on echocardiographic measurements alone.